CLINICAL_TRIALS
trial_result
· 2014-12-18
Clinical Trial Update: A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS) [Phase 3]
Summary
Phase 3 trial CADMUS reports safety and efficacy results for ustekinumab in adolescent psoriasis; results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2014-12-18